List of insiders holdings for LA JOLLA PHARMACEUTICAL CO:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BIOMARIN PHARMACEUTICAL INC 10% Owner | 2009-06-24 16:45:15 | 3,280,568 0 | 3,280,568 | Form 13D |
| 2 | ENGBERS WILLIAM Director | 2005-05-20 18:49:18 | 1,699,540 0 | 1,699,540 | Form 4 |
| 3 | TIDMARSH GEORGE F President, CEO & Secretary | 2019-04-17 17:04:23 | 1,263,897 22,000 | 1,285,897 | Form 4 |
| 4 | Gonzalez Alejandro 10% Owner | 2009-02-13 11:45:09 | 1,138,147 0 | 1,138,147 | Form 13G |
| 5 | Reinisch Richard Individual Investor | 2013-03-22 15:39:16 | 1,100,000 0 | 1,100,000 | Form 4 |
| 6 | ENGLE STEVEN B CEO & Chairman | 2006-02-10 13:05:47 | 685,406 0 | 685,406 | Form 5 |
| 7 | WELCH WILLIAM J VP Sales & Marketing | 2005-05-20 17:19:59 | 474,409 0 | 474,409 | Form 4 |
| 8 | MARTIN STEPHEN Director | 2010-06-02 15:06:30 | 300,000 0 | 300,000 | Form 4 |
| 9 | Liang Bertrand C. Director | 2010-12-08 15:37:20 | 300,000 0 | 300,000 | Form 4 |
| 10 | FILDES ROBERT PHD Director | 2010-06-02 15:04:44 | 300,000 0 | 300,000 | Form 4 |
| 11 | HEILBRUNN KENNETH R VP of Clinical Development | 2005-04-05 13:14:55 | 208,214 0 | 208,214 | Form 4 |
| 12 | Zarrabian Saiid Director | 2015-05-15 16:44:37 | 109,231 688 | 109,919 | Form 4 |
| 13 | BENNETT BRUCE K JR VP of Manufacturing | 2006-04-18 16:47:06 | 107,816 431 | 108,247 | Form 4 |
| 14 | REILLY TEDDI VP of Human Resources | 2006-04-18 16:47:47 | 106,385 0 | 106,385 | Form 4 |
| 15 | THOMPSON W LEIGH MD PHD Former Director Director | 2004-05-25 22:00:11 | 0 83,000 | 83,000 | Form 4 |
| 16 | Rolke James Chief Scientific Officer | 2020-06-02 16:02:20 | 81,976 0 | 81,976 | Form 4 |
| 17 | Chawla Lakhmir S Chief Medical Officer | 2020-09-17 16:57:20 | 73,733 0 | 73,733 | Form 4 |
| 18 | CAVIAR NIV EDWARD Chief Business Officer & CFO | 2009-02-03 18:04:15 | 55,000 0 | 55,000 | Form 4/A |
| 19 | TANSEY MICHAEL JAMES BYRON Executive VP & CMO | 2009-02-03 18:03:18 | 45,000 0 | 45,000 | Form 4/A |
| 20 | WISEMAN ANDREW Sen Dir Investor Relations | 2007-02-07 18:47:44 | 42,052 0 | 42,052 | Form 4 |
| 21 | SEIKKULA LUKE Vice President Manufacturing | 2009-02-03 18:06:56 | 35,000 0 | 35,000 | Form 4/A |
| 22 | CARVER JENNIFER Chief Operating Officer | 2019-03-04 17:30:59 | 14,279 0 | 14,279 | Form 4 |
| 23 | KOCH LISA I VP Regulatory & Project Mgmt. | 2007-02-07 18:48:40 | 12,500 0 | 12,500 | Form 4 |
| 24 | RINGO WILLIAM R Director | 2004-05-25 21:31:43 | 11,000 0 | 11,000 | Form 4 |
| 25 | YOUNG FRANK Director | 2008-05-23 16:17:03 | 10,000 0 | 10,000 | Form 4 |
| 26 | ADAMS THOMAS PHD Director | 2008-05-23 18:12:17 | 10,000 0 | 10,000 | Form 4 |
| 27 | Naini Nader J Director | 2007-05-24 18:24:48 | 10,000 0 | 10,000 | Form 4 |
| 28 | Wellinghoff Darryl Chief Commercial Officer | 2020-04-17 16:03:16 | 9,538 0 | 9,538 | Form 4 |
| 29 | MULROY DENNIS Chief Financial Officer | 2020-06-02 16:03:04 | 5,149 0 | 5,149 | Form 4 |
| 30 | LINNIK MATTHEW D CSO & Exec VP of Research | 2006-12-27 17:19:21 | 1,300 0 | 1,300 | Form 4 |
| 31 | SLOAN GAIL A Chief Financial Officer | 2011-04-21 20:13:36 | 1,120 0 | 1,120 | Form 4 |
| 32 | JENN PAUL VP of Product Development | 2007-01-11 19:47:37 | 526 0 | 526 | Form 4 |
| 33 | Gillespie Deirdre President & CEO | 2011-05-18 19:55:53 | 111.2 0 | 111.2 | Form 4 |
| 34 | Frazier Healthcare V LP FHM V LLC FHM V LP 10% Owner | 2009-03-02 17:14:54 | 0 0 | 0 | Form 13D |
| 35 | Topper James N Director | 2009-02-26 18:09:40 | 0 0 | 0 | Form 4 |
| 36 | SMITH CRAIG R Director | 2009-02-27 17:46:09 | 0 0 | 0 | Form 4 |
| 37 | Elchico Josefina T VP Quality Operations | 2009-03-05 16:07:20 | 0 0 | 0 | Form 4 |
| 38 | ESSEX WOODLANDS HEALTH VENTURES FUND VI L P 10% Owner | 2009-08-07 16:45:52 | 0 0 | 0 | Form 4 |
| 39 | ESSEX WOODLANDS HEALTH VENTURES FUND VII LP 10% Owner | 2009-08-07 16:46:19 | 0 0 | 0 | Form 4 |
| 40 | SUTTER MARTIN P Director | 2009-08-07 16:48:23 | 0 0 | 0 | Form 4 |
| 41 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2020-02-14 15:59:02 | 0 0 | 0 | Form 13G |
| 42 | Rosen Robert Director | 2022-08-24 20:27:43 | 0 0 | 0 | Form 4 |
| 43 | RAMSAY DAVID A Director | 2022-08-24 20:22:23 | 0 0 | 0 | Form 4 |
| 44 | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 2022-08-24 16:02:16 | 0 0 | 0 | Form 4 |
| 45 | TANG KEVIN C Director 10% Owner | 2022-08-24 20:21:25 | 0 0 | 0 | Form 4 |
| 46 | Edwards Larry G. Chief Executive Officer | 2022-08-24 20:20:36 | 0 0 | 0 | Form 4 |
| 47 | Hearne Michael S Chief Financial Officer | 2022-08-24 20:19:10 | 0 0 | 0 | Form 4 |
| 48 | Johnson Laura L. Director | 2022-08-24 20:18:06 | 0 0 | 0 | Form 4 |
| 49 | Johnson Craig A Director | 2022-08-24 20:17:54 | 0 0 | 0 | Form 4 |